| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | N/A | N/A | N/A | N/A | N/A |
| MA10 | N/A | N/A | N/A | N/A | N/A |
| MA20 | N/A | N/A | N/A | N/A | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | N/A | N/A |
| STOCH | N/A | N/A | N/A | N/A | N/A |
| WILL %R | N/A | N/A | N/A | N/A | N/A |
| CCI | N/A | N/A | N/A | N/A | N/A |
|
Monday, October 19, 2026 03:00 PM
IRulya Therapeutics Inc.: Evolution du consensus et de l'objectif de cours des analystes Action IRulya Therapeutics Inc. | IRLA | US22053A3059 | Nasdaq ...
|
|
Thursday, October 15, 2026 01:00 AM
IRulya Therapeutics Inc. (Nasdaq: IRLA), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapeutics for serious underserved diseases, today ...
|
|
Friday, October 09, 2026 05:39 AM
Quince Therapeutics (NASDAQ:QNCX) has changed its name to IRulya Therapeutics Inc., effective October 9, 2026, as the biotechnology company shifts its focus towards developing an inhaled treatment for ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 19/10/26 | 31.17 | 34.61 | 31.01 | 34.45 | 41,592 |
|
|
||||
|
|
||||
|
|